Paper36795489
The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.
Zhang Z and 16 others. JCI Insight, 2023. Cited by 12 papers, by iCite.
Cite this record
ConductScience Library. The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment. Papers, record 36795489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36795489
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The m6A methyltransferase METTL16 negatively regulates MCP1 expression in mesenchymal stem cells during monocyte recruitment.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Monocytes | Major topic |
| Mesenchymal Stem Cells | Major topic |
| Chemokine CCL2 | |
| Adenosine | |
| Methyltransferases |
Source PubMed
References45
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30870073 | METTL3 and ALKBH5 oppositely regulate m6A modification of TFEB mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes. | Autophagy | 2019 | https://conductscience.org/library/papers/30870073 | PubMed |
| 2 | 35145225 | METTL16 exerts an m6A-independent function to facilitate translation and tumorigenesis. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/35145225 | PubMed |
| 3 | 28186704 | Mesenchymal Stromal Cells Modulate Monocytes Trafficking in Coxsackievirus B3-Induced Myocarditis. | Stem Cells Transl Med | 2017 | https://conductscience.org/library/papers/28186704 | PubMed |
| 4 | 34528765 | Mesenchymal stromal cell-secreted CCL2 promotes antibacterial defense mechanisms through increased antimicrobial peptide expression in keratinocytes. | Stem Cells Transl Med | 2021 | https://conductscience.org/library/papers/34528765 | PubMed |
| 5 | 33021671 | RMVar: an updated database of functional variants involved in RNA modifications. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/33021671 | PubMed |
| 6 | 34508078 | TNF-α-mediated m6A modification of ELMO1 triggers directional migration of mesenchymal stem cell in ankylosing spondylitis. | Nat Commun | 2021 | https://conductscience.org/library/papers/34508078 | PubMed |
| 7 | 30784918 | The role of m6A RNA methylation in cancer. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30784918 | PubMed |
| 8 | 21220697 | Chemokine transcripts as targets of the RNA-binding protein HuR in human airway epithelium. | J Immunol | 2011 | https://conductscience.org/library/papers/21220697 | PubMed |
| 9 | 22575960 | Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. | Nature | 2012 | https://conductscience.org/library/papers/22575960 | PubMed |
| 10 | 32071558 | Mesenchymal stromal cells promote liver regeneration through regulation of immune cells. | Int J Biol Sci | 2020 | https://conductscience.org/library/papers/32071558 | PubMed |
| 11 | 34228629 | The Emerging Roles of RNA m6A Methylation and Demethylation as Critical Regulators of Tumorigenesis, Drug Sensitivity, and Resistance. | Cancer Res | 2021 | https://conductscience.org/library/papers/34228629 | PubMed |
| 12 | 31998240 | Regulatory Role of RNA N6-Methyladenosine Modification in Bone Biology and Osteoporosis. | Front Endocrinol (Lausanne) | 2019 | https://conductscience.org/library/papers/31998240 | PubMed |
| 13 | 33470439 | m6 A RNA methylation: from mechanisms to therapeutic potential. | EMBO J | 2021 | https://conductscience.org/library/papers/33470439 | PubMed |
| 14 | 28809393 | Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis. | Cell Res | 2017 | https://conductscience.org/library/papers/28809393 | PubMed |
| 15 | 31780844 | Chemical inhibitors make their RNA epigenetic mark. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/31780844 | PubMed |
| 16 | 32183948 | m6A Modification in Coding and Non-coding RNAs: Roles and Therapeutic Implications in Cancer. | Cancer Cell | 2020 | https://conductscience.org/library/papers/32183948 | PubMed |
| 17 | 33096826 | Enhancing the Therapeutic Potential of CCL2-Overexpressing Mesenchymal Stem Cells in Acute Stroke. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/33096826 | PubMed |
| 18 | 32060374 | Mesenchymal stromal cell derived CCL2 is required for accelerated wound healing. | Sci Rep | 2020 | https://conductscience.org/library/papers/32060374 | PubMed |
| 19 | 31424112 | CCL2 But Not CCR2 Is Required for Spontaneous Articular Cartilage Regeneration Post-Injury. | J Orthop Res | 2019 | https://conductscience.org/library/papers/31424112 | PubMed |
| 20 | 30388208 | Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice. | Cardiovasc Res | 2019 | https://conductscience.org/library/papers/30388208 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41645746 | N6‑methyladenosine reader insulin‑like growth factor 2 mRNA‑binding protein 2 promotes abnormal proliferation of colonic epithelial cells in type 2 diabetes mellitus by regulating midkine. | Mol Med Rep | 2026 | https://conductscience.org/library/papers/41645746 | PubMed |
| 41459114 | METTL16 in cancer: Roles and regulatory mechanisms. | Genes Dis | 2026 | https://conductscience.org/library/papers/41459114 | PubMed |
| 41436435 | TNF-α-driven m6A modification disrupts the immunoregulatory function of MSCs by regulating HDAC5-dependent super-enhancers. | Cell Death Dis | 2025 | https://conductscience.org/library/papers/41436435 | PubMed |
| 39218945 | METTL16-SENP3-LTF axis confers ferroptosis resistance and facilitates tumorigenesis in hepatocellular carcinoma. | J Hematol Oncol | 2024 | https://conductscience.org/library/papers/39218945 | PubMed |
| 39155349 | METTL Family in Healthy and Disease. | Mol Biomed | 2024 | https://conductscience.org/library/papers/39155349 | PubMed |
| 38655088 | Immunomodulatory effects of hydatid antigens on mesenchymal stem cells: gene expression alterations and functional consequences. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38655088 | PubMed |
| 38601938 | Exploration of altered miRNA expression and function in MSC-derived extracellular vesicles in response to hydatid antigen stimulation. | Front Microbiol | 2024 | https://conductscience.org/library/papers/38601938 | PubMed |
| 37985811 | Epitranscriptomic modifications in mesenchymal stem cell differentiation: advances, mechanistic insights, and beyond. | Cell Death Differ | 2024 | https://conductscience.org/library/papers/37985811 | PubMed |
Genes16
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36795489
GET https://conductscience.org/api/papers/v1/36795489/references?page=2